Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
Pérez-Plaza A, Carretero G, Ferrandiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Rivera R, Jiménez-Puya R, García-Doval I, Descalzo MA; Biobadaderm Study Group. Pérez-Plaza A, et al. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-1028. doi: 10.1111/jdv.14188. Epub 2017 Apr 12. J Eur Acad Dermatol Venereol. 2017. PMID: 28252811
Multiple eruptive dermatofibromas related to imatinib treatment.
Llamas-Velasco M, Fraga J, Solano-López GE, Steegmann JL, García Diez A, Requena L. Llamas-Velasco M, et al. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):979-81. doi: 10.1111/jdv.12328. Epub 2013 Dec 10. J Eur Acad Dermatol Venereol. 2014. PMID: 24321053 No abstract available.
Biological Treatments in Atopic Dermatitis.
Montes-Torres A, Llamas-Velasco M, Pérez-Plaza A, Solano-López G, Sánchez-Pérez J. Montes-Torres A, et al. J Clin Med. 2015 Apr 3;4(4):593-613. doi: 10.3390/jcm4040593. J Clin Med. 2015. PMID: 26239349 Free PMC article. Review.
Eccrine porocarcinoma with extensive cutaneous metastases.
Montes-Torres A, Pérez-Plaza A, Llamas-Velasco M, Gordillo C, De Argila D, García-García C, Fraga J, Marín A, Ballesteros AI, Daudén E. Montes-Torres A, et al. Int J Dermatol. 2016 Mar;55(3):e156-60. doi: 10.1111/ijd.13121. Epub 2015 Nov 13. Int J Dermatol. 2016. PMID: 26566927
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.
Galiano Mejías S, Carretero G, Ferrandiz C, Vanaclocha F, Daudén E, Gómez-García FJ, Herrera-Ceballos E, Belinchón-Romero I, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Rivera R, Llamas-Velasco M, Jiménez-Puya R, Mendiola MV, Ruiz-Genao D, Descalzo MA, de la Cueva Dobao P; del grupo Biobadaderm. Galiano Mejías S, et al. Actas Dermosifiliogr. 2017 Jan-Feb;108(1):52-58. doi: 10.1016/j.ad.2016.08.003. Epub 2016 Sep 20. Actas Dermosifiliogr. 2017. PMID: 27658689 Free article. English, Spanish.
IL17RA gene variants and anti-TNF response among psoriasis patients.
Batalla A, Coto E, Gómez J, Eirís N, González-Fernández D, Gómez-De Castro C, Daudén E, Llamas-Velasco M, Prieto-Perez R, Abad-Santos F, Carretero G, García FS, Godoy YB, Cardo LF, Alonso B, Iglesias S, Coto-Segura P. Batalla A, et al. Pharmacogenomics J. 2018 Jan;18(1):76-80. doi: 10.1038/tpj.2016.70. Epub 2016 Sep 27. Pharmacogenomics J. 2018. PMID: 27670766
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
Belinchón I, Ramos JM, Carretero G, Ferrándiz C, Rivera R, Daudén E, De la Cueva-Dobao P, Gómez-García FJ, Herrera-Ceballos E, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Ortiz PL, García-Doval I, Descalzo MA; Biobadaderm Study Group. Belinchón I, et al. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1700-1708. doi: 10.1111/jdv.14314. Epub 2017 Jun 6. J Eur Acad Dermatol Venereol. 2017. PMID: 28485816
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study.
Descalzo MA, Carretero G, Ferrándiz C, Rivera R, Daudén E, Gómez-García FJ, de la Cueva P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Baniandrés O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Muñoz-Santos C, García-Doval I; Biobadaderm Study Group. Descalzo MA, et al. J Am Acad Dermatol. 2018 Apr;78(4):798-800. doi: 10.1016/j.jaad.2017.10.051. Epub 2017 Nov 13. J Am Acad Dermatol. 2018. PMID: 29146129 Free article. No abstract available.
Pseudolymphomatous Granuloma Annulare: A Little-Known Variant.
Llamas-Velasco M, Urquina-Renke A, Pérez-Plaza A, Fraga J. Llamas-Velasco M, et al. Actas Dermosifiliogr (Engl Ed). 2019 Mar;110(2):162-164. doi: 10.1016/j.ad.2017.10.027. Epub 2018 May 31. Actas Dermosifiliogr (Engl Ed). 2019. PMID: 29861038 English, Spanish. No abstract available.
Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016.
Carretero Hernández G, Ferrándiz C, Rivera Díaz R, Daudén Tello E, de la Cueva-Dobao P, Gómez-García FJ, Herrera-Ceballos E, Belinchón Romero I, López-Estebaranz JL, Alsina Gibert M, Sánchez-Carazo JL, Ferrán Farrés M, González Quesada A, Carrascosa Carrillo JM, Llamas-Velasco M, Mendiola Fernández MV, Ruiz Genao D, Muñoz Santos C, García-Doval I, Descalzo MA; grupo de estudio de Biobadaderm. Carretero Hernández G, et al. Actas Dermosifiliogr (Engl Ed). 2018 Sep;109(7):617-623. doi: 10.1016/j.ad.2018.04.004. Epub 2018 Jun 7. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 29887167 English, Spanish.
232 results